AMENDED AND RESTATED MULTI DRAW CREDIT AGREEMENTMulti Draw Credit Agreement • April 29th, 2020 • Emerald Bioscience, Inc. • Pharmaceutical preparations • California
This Amended and Restated Multi Draw Credit Agreement is entered into as of April 1, 2020 (as the same may be further amended, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), by and between EMERALD BIOSCIENCE, INC.(previously named Nemus Bioscience, Inc.), a Nevada corporation (the “Company”) and Emerald HEALTH SCIENCES, Inc., (the “Lender” and together with the Company, the “Parties”).
AMENDMENT NO. 3 MULTI DRAW CREDIT AGREEMENTMulti Draw Credit Agreement • March 28th, 2022 • Skye Bioscience, Inc. • Pharmaceutical preparations • California
This Amendment (this “Amendment”) is made and entered into as of September 15, 2021, by and between Skye Bioscience, Inc., a corporation incorporated under the laws of the state of Nevada (the “Company”), and Emerald Health Sciences Inc., a corporation incorporated under the laws of British Columbia (the “Lender”). The above parties are referred to collectively herein as the “Parties,” and individually as a “Party.”
AMENDMENT NO. 5 MULTI DRAW CREDIT AGREEMENTMulti Draw Credit Agreement • January 6th, 2023 • Skye Bioscience, Inc. • Pharmaceutical preparations
This Amendment (this “Amendment”) is made and entered into as of December 30, 2022, by and between Skye Bioscience, Inc., a corporation incorporated under the laws of the state of Nevada (the “Company”), and Emerald Health Sciences Inc., a corporation incorporated under the laws of British Columbia (the “Lender”). The above parties are referred to collectively herein as the “Parties,” and individually as a “Party.”
